Shepherd Center, Inc.

Atlanta, Georgia 30309

1 studies enrolling now · 16 studies all time

What they study most

Human, Interstitial Cystitis, Multiple Sclerosis, Multiple Sclerosis, Relapsing, Multiple Sclerosis, Relapsing-Remitting, Muscle Spasticity, Pain, Patients With Severe Chronic Pain, Relapsing Multiple Sclerosis, Spasticity, Spinal Cord Injuries, Spinal Cord Injury

Studies at this site

• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis — Recruiting now
• Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury — Recruiting now
• Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab — Completed
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• Influence of Transcutaneous Spinal Stimulation Intensity on Spasticity After SCI — Completed
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• Spinal Cord Stimulation to Augment Activity Based Therapy — Completed
• Enhancing Corticospinal Activation for Improved Walking Function — Completed
• Dose-Response Effects of Whole Body Vibration on Spasticity and Walking in SCI — Completed
• Conditioning Neural Circuits to Improve Upper Extremity Function — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed
• Patient Registry of Intrathecal Ziconotide Management(PRIZM) — Completed
• Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain — Completed
• Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis — Completed
• Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury — Stopped early